今天,ICS含有救援疗法与SABA单独在喘管理中的作用
James G Krings1, Richard Beasley2
1Division of Pulmonary and Critical Care Medicine, Washington University in St. Louis School of Medicine, St. Louis, Mo.
The journal of allergy and clinical immunology. In practice
|January 18, 2024
概括
全球喘倡议 (GINA) 建议在轻度喘中优先使用吸入性皮质类固醇 (ICS) - 形式醇进行缓解疗法,而不是短效β2-激动剂 (SABA) 单疗. 这种方法减少了严重的恶化,并提供了更好的风险/益处概况.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 全球喘倡议 (GINA) 的指导方针提倡在轻度喘中不采用短效β2-激动剂 (SABA) 单疗法.
- 如有需要的吸入性皮质类固醇 (ICS) -formoterol现在是成人和青少年轻度喘的首选缓解疗法.
- 这一转变是基于SABA单一治疗的风险和ICS-formoterol在减少严重恶化中已被证明的疗效.
研究的目的:
- 为了比较ICS-formoterol和ICS-albuterol缓解疗法的长期安全性和疗效与SABA单疗法.
- 为了评估ICS-formoterol与SABA的直接支气管扩展效应.
- 讨论影响缓解器吸入器选择轻度喘的临床和监管因素.
主要方法:
- 对喘缓解疗法的现有研究进行系统审查和比较.
- 对ICS-formoterol,ICS-albuterol和SABA缓解剂策略的优缺点分析.
- 安全性,疗效,支气管扩展效果的评估,以及临床/监管方面的考虑.
主要成果:
- 与单独使用SABA相比,ICS-formoterol缓解疗法显示严重喘恶化显著减少.
- ICS-formoterol提供了一个有利的风险/收益概况与维护ICS与SABAreliever相比.
- 在轻度喘中ICS-albuterol的证据不那么广泛,但信息丰富.
结论:
- 目前的证据支持ICS-formoterol作为轻度喘的首选缓解疗法,提高安全性和减少恶化.
- 需要进一步研究ICS-albuterol在轻度喘中的有效性和实施.
- 临床和监管因素在选择适当的缓解吸入器策略方面发挥着作用.
相关概念视频
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
252
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
252
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:29Acute Respiratory Failure-V
141
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
141
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
267
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
267
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
01:17Drugs Used in Lower Respiratory Disorders: Overview
445
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
445